Ann: Breakthrough Results a Major Step Towards Commercialisation, page-75

Must say, this is an incredible BET reward case.

Noting the above links

27 million mams in USA, PA
0.9m mams in AUS, PA
How many more world wide ? And how many more who dont get a mam, would want a simple blood test ?And think other age ranges, as cancers occur in younger and younger populations.

Diagnostic conga line, is better volume x margins than trying to cure.?
Because more people will want to be tested, than of those who are sick. The numbers here, as i've pointed out, with some vagaries on net margins from the 350 revenue per test, is mind blowing.

20 million tests PA eg. could be talking billions in profits.
Think big, see the prize. If it can be applied in AUS, it can be applied world wide.
What that growth path does to this tiny 24m stock today ?
It gets taken over most likely somewhere in between the Australian market, to the wider world adoption.

And if AI can use IP to detect other cancer types ?